Photo: Maria Sbytova/Adobe Stock FidoCure, the flagship brand of the One Health Company, has been granted a patent for a novel targeted therapy and biomarker for canine cancer by the US Patent and Trademark Office (USPTO). The patent covers a new approach to treatment, using mutation profiling to better manage bladder cancer in dogs.1 The